These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9582087)

  • 21. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo.
    Nierodzik ML; Klepfish A; Karpatkin S
    Thromb Haemost; 1995 Jul; 74(1):282-90. PubMed ID: 8578473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.
    Krishn SR; Singh A; Bowler N; Duffy AN; Friedman A; Fedele C; Kurtoglu S; Tripathi SK; Wang K; Hawkins A; Sayeed A; Goswami CP; Thakur ML; Iozzo RV; Peiper SC; Kelly WK; Languino LR
    Matrix Biol; 2019 Apr; 77():41-57. PubMed ID: 30098419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential.
    Timár J; Rásó E; Döme B; Li L; Grignon D; Nie D; Honn KV; Hagmann W
    Int J Cancer; 2000 Jul; 87(1):37-43. PubMed ID: 10861450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway.
    Zheng DQ; Woodard AS; Fornaro M; Tallini G; Languino LR
    Cancer Res; 1999 Apr; 59(7):1655-64. PubMed ID: 10197643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Nod Scid mouse model to study human prostate cancer.
    Bastide C; Bagnis C; Mannoni P; Hassoun J; Bladou F
    Prostate Cancer Prostatic Dis; 2002; 5(4):311-5. PubMed ID: 12627217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
    Leclerc JR
    Crit Care Med; 2002 May; 30(5 Suppl):S332-40. PubMed ID: 12004256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors.
    González-Manchón C; Butta N; Larrucea S; Arias-Salgado EG; Alonso S; López A; Parrilla R
    Thromb Haemost; 2004 Dec; 92(6):1377-86. PubMed ID: 15583747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role for beta3 integrins in human melanoma growth and survival.
    Trikha M; Timar J; Zacharek A; Nemeth JA; Cai Y; Dome B; Somlai B; Raso E; Ladanyi A; Honn KV
    Int J Cancer; 2002 Sep; 101(2):156-67. PubMed ID: 12209993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic binding partners of the platelet integrin alphaIIb beta3.
    Bonner MA; Naik UP
    Front Biosci; 2007 Jan; 12():2038-49. PubMed ID: 17127442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversion of human prostate tumorigenic growth by azatyrosine.
    Benoit RM; Eiseman J; Jacobs SC; Kyprianou N
    Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial growth suppression of human prostate cancer cells by the Krev-1 suppressor gene.
    Burney TL; Rockove S; Eiseman JL; Jacobs SC; Kyprianou N
    Prostate; 1994 Oct; 25(4):177-88. PubMed ID: 8084835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical roles for the COOH-terminal NITY and RGT sequences of the integrin beta3 cytoplasmic domain in inside-out and outside-in signaling.
    Xi X; Bodnar RJ; Li Z; Lam SC; Du X
    J Cell Biol; 2003 Jul; 162(2):329-39. PubMed ID: 12860973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mechanistic model for paradoxical platelet activation by ligand-mimetic alphaIIb beta3 (GPIIb/IIIa) antagonists.
    Bassler N; Loeffler C; Mangin P; Yuan Y; Schwarz M; Hagemeyer CE; Eisenhardt SU; Ahrens I; Bode C; Jackson SP; Peter K
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):e9-15. PubMed ID: 17170374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration.
    Udayakumar TS; Chen ML; Bair EL; Von Bredow DC; Cress AE; Nagle RB; Bowden GT
    Cancer Res; 2003 May; 63(9):2292-9. PubMed ID: 12727852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
    Xue W; Mizukami I; Todd RF; Petty HR
    Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.
    Ren B; Yu YP; Tseng GC; Wu C; Chen K; Rao UN; Nelson J; Michalopoulos GK; Luo JH
    J Natl Cancer Inst; 2007 Jun; 99(11):868-80. PubMed ID: 17551147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude mice.
    Bex A; Wullich B; Endris V; Otto T; Rembrink K; Stöckle M; Rübben H
    Cancer Genet Cytogenet; 2001 Jan; 124(2):98-104. PubMed ID: 11172899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.